CA
NZ
UK
AU
IND
US
Patient and resident service revenue was USD 1,498,137 thousand versus USD 1,344,302 thousand, and other revenues were USD 441 thousand versus USD 265 thousand. For the nine months ended September 30, 2026, total revenue was USD 4,347,070 thousand versus USD 3,930,953 thousand, and patient …
GAAP gross margin was 80% and non-GAAP gross margin was 84%.Gross Profitwas USD 323.6 million. Operating expenses rose to USD 330.8 million from USD 285.1 million, withResearch and Developmentat USD 108.5 million against USD 88.0 million and general and administrative at USD 72.3 million …
Group adjusted EBITA margin increased by 70 basis points year over year to 13%, driven by higher sales, improved gross margin, a growing contribution from higher-margin innovations and productivity delivery, with a modest benefit from more favorableTariffrates. Adjusted EPS increased more than 10% year …
Net income was USD 51.3 million, or USD 0.95 per diluted share, compared with USD 94.6 million, or USD 1.73, a year earlier. The company attributes the decline largely to lower operating income, from lower revenue and gross profit, and higher interest expense. AdjustedNet …
Chairman and Chief Executive Officer Andy Sullivan said lower earnings in Japan related to the sales suspension at Prudential of Japan more than offset results in PGIM and the U.S. businesses. The company attributes the decline to the sales suspension, including higher expenses and …
Rental income was USD 29,651 thousand versus USD 23,692 thousand, and fee and otherRevenuewas USD 627 thousand versus USD 634 thousand. For the nine months ended September 30, 2026, total revenues were USD 85,508 thousand versus USD 69,827 thousand, and rental income was USD …
Average total degreed enrollment was 83,700 versus 81,900, an increase of 2.2% that the filing attributes primarily to improved student retention. The filing states that the increase in net revenue was partially offset by higher discounts, resulting from a higher percentage of enrollment through …
Labs revenue was USD 353 million, down 6%, primarily because of lower sales in China tied to recently announced changes to in vitro diagnostics pricing. Outside China, Labs revenue grew 3% as reported and 4% in constant currency. Immunohematology revenue was USD 142 million, …
Net revenues increased 7% including the currency headwind, mainly related to the U.S. dollar and Japanese yen. The increase in cars and spare parts was driven by product mix and higher personalizations, which surpassed 21% of total revenues from cars and spare parts and …
The quarter included two first-ever FDA approvals for gene therapies. Genglycos, an AAV8 therapy for glycogen storage disease type Ia, receivedAccelerated Approvalin August for patients aged eight and older, and Fayuvi, an AAV9 therapy for Sanfilippo syndrome type A, received standard full approval in …
Please wait processing your request...